Titan Biotech Ltd

Titan Biotech Ltd

₹ 426 -0.69%
19 Jun 1:13 p.m.
About

Incorporated in 1992, Titan Biotech
Ltd manufacturer and exporter of
the Biological products[1]

Key Points

Business Overview:[1]
TBL is an ISO 9001:2008 Certified & cGMP facilitated manufacturer & exporter of biological products used in the fields of Pharmaceutical, Nutraceutical, Food & Beverages, Biotechnology & Fermentation, Cosmetic, Veterinary & Animal
Feed, Agriculture Industries, Microbiology Culture Media & Plant Tissue Culture Media,
etc.

  • Market Cap 1,758 Cr.
  • Current Price 426
  • High / Low 556 / 76.8
  • Stock P/E 64.0
  • Book Value 41.4
  • Dividend Yield 0.09 %
  • ROCE 24.1 %
  • ROE 17.4 %
  • Face Value 2.00

Pros

  • Company is almost debt free.
  • Company is expected to give good quarter

Cons

  • Stock is trading at 10.3 times its book value
  • The company has delivered a poor sales growth of 11.0% over past five years.
  • Dividend payout has been low at 7.85% of profits over last 3 years

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
36.84 34.75 43.43 45.98 39.92 43.11 39.89 38.28 35.17 46.50 54.35 56.51 48.83
30.00 26.86 34.71 35.38 32.85 34.86 32.13 33.43 30.60 37.76 45.02 45.68 39.12
Operating Profit 6.84 7.89 8.72 10.60 7.07 8.25 7.76 4.85 4.57 8.74 9.33 10.83 9.71
OPM % 18.57% 22.71% 20.08% 23.05% 17.71% 19.14% 19.45% 12.67% 12.99% 18.80% 17.17% 19.16% 19.89%
0.49 0.28 0.55 0.44 0.48 0.62 0.32 1.59 1.38 0.72 1.32 1.26 2.11
Interest 0.26 0.29 0.28 0.26 0.34 0.31 0.27 0.15 0.08 0.20 0.22 0.26 0.24
Depreciation 0.71 0.80 0.86 0.83 0.84 1.05 1.10 1.18 0.84 1.15 1.21 1.27 1.30
Profit before tax 6.36 7.08 8.13 9.95 6.37 7.51 6.71 5.11 5.03 8.11 9.22 10.56 10.28
Tax % 26.89% 23.73% 25.71% 25.63% 24.02% 24.23% 25.48% 25.64% 25.25% 24.04% 25.60% 25.57% 36.19%
4.64 5.41 6.03 7.38 4.84 5.70 5.00 3.80 3.77 6.16 6.86 7.87 6.56
EPS in Rs 1.12 1.31 1.46 1.79 1.17 1.38 1.21 0.92 0.91 1.49 1.66 1.91 1.59
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
40 46 52 56 58 69 122 124 144 164 156 206
36 42 47 49 51 59 81 92 114 130 131 168
Operating Profit 4 4 6 7 8 11 42 31 30 34 25 39
OPM % 10% 9% 10% 12% 13% 16% 34% 25% 21% 21% 16% 19%
0 0 0 0 1 1 0 1 2 2 4 5
Interest 1 1 1 2 2 2 1 1 1 1 1 1
Depreciation 1 1 1 1 2 2 2 2 3 3 4 5
Profit before tax 2 3 3 4 4 8 39 29 28 32 24 38
Tax % 33% 33% 33% 36% 29% 25% 26% 25% 25% 25% 25% 28%
2 2 2 2 3 6 29 22 21 24 18 27
EPS in Rs 0.42 0.44 0.60 0.62 0.75 1.50 6.97 5.25 5.09 5.73 4.42 6.64
Dividend Payout % 36% 34% 25% 24% 0% 13% 4% 6% 7% 7% 9% 8%
Compounded Sales Growth
10 Years: 16%
5 Years: 11%
3 Years: 13%
TTM: 32%
Compounded Profit Growth
10 Years: 32%
5 Years: -1%
3 Years: 9%
TTM: 50%
Stock Price CAGR
10 Years: 52%
5 Years: 42%
3 Years: 103%
1 Year: 440%
Return on Equity
10 Years: 21%
5 Years: 19%
3 Years: 17%
Last Year: 17%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 8 8 8 8 8 8 8 8 8 8 8 8
Reserves 13 14 15 17 23 30 58 78 98 120 137 163
8 11 22 25 22 18 10 9 9 8 3 6
5 6 5 5 6 10 10 13 16 15 19 27
Total Liabilities 34 39 50 55 60 65 86 108 131 152 166 203
11 10 11 11 26 25 27 35 36 52 57 62
CWIP 1 5 9 13 0 0 0 4 13 3 2 2
Investments 0 1 1 1 1 1 1 4 12 23 24 50
21 23 29 29 33 39 58 65 70 74 83 90
Total Assets 34 39 50 55 60 65 86 108 131 152 166 203

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
-2 5 -0 2 6 7 18 22 21 21 20 30
-3 -5 -7 -5 -4 -1 -4 -16 -21 -20 -10 -34
3 2 8 0 -2 -6 -10 -4 -2 -3 -8 0
Net Cash Flow -2 2 2 -3 1 0 4 2 -2 -2 2 -4
Free Cash Flow -3 1 -6 -3 2 6 13 8 8 12 12 21
CFO/OP -28% 143% 18% 39% 95% 78% 66% 93% 97% 85% 103% 101%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 58 46 44 53 49 55 48 48 53 42 44 40
Inventory Days 134 118 155 202 238 244 177 206 179 208 242 212
Days Payable 17 18 13 12 25 36 18 25 27 15 25 32
Cash Conversion Cycle 175 145 186 243 262 263 207 230 205 234 261 220
Working Capital Days 94 58 86 111 101 105 89 118 109 112 130 102
ROCE % 14% 12% 13% 13% 13% 18% 61% 35% 28% 26% 18% 24%

Insights

In beta
Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Number of Permanent Employees
Number

Log in to view insights

Please log in to see hidden values.

Login
Electricity Consumption per unit of production
Units/kg
Number of Manufacturing Plants
Number

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
55.87% 55.87% 55.87% 55.87% 55.87% 55.87% 55.87% 55.87% 55.87% 55.78% 55.78% 55.78%
0.00% 0.00% 0.00% 0.23% 0.00% 0.00% 0.00% 0.01% 0.03% 0.03% 0.03% 0.03%
44.13% 44.13% 44.12% 43.90% 44.12% 44.13% 44.12% 44.11% 44.10% 44.19% 44.19% 44.19%
No. of Shareholders 18,10617,45515,75615,87615,85015,70016,03816,37016,32816,04016,36717,457

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents